How Cardiac Intelligence Platforms Detect Myocardial Stress & Heart Failure Early with Chris Darland
PureBridge Health CEO Chris Darland says current cardiac care is largely reactive and misses progressive heart disease until patients end up in the ER. Drawing on personal experience and a nonclinical background, he frames the company’s mission as building inexpensive, scalable diagnostic and monitoring tools that bring hospital-grade detection for myocardial stress and heart failure into communities. PureBridge plans to leverage AI and data to create accessible, clinically sophisticated platforms that detect varied cardiac problems (arrhythmia, structural, vascular) earlier than today’s episodic hospital-based model. The company emphasizes cost-effective deployment versus expensive point-of-care options to reach underserved populations and reduce surprise hospitalizations.
Chamath Was Right: Attention Is the Operating System of AI, Media, and Markets
The video argues that attention functions as the operating system behind artificial intelligence, media platforms, and market formation. Chamath’s "Attention is all you need" thesis is extended beyond the original transformer paper, suggesting that algorithms are engineered solely to capture...
What Makes MedTech Startups So Unique Compared to SaaS!
The video explores why med‑tech startups differ fundamentally from SaaS companies, emphasizing the binary, make‑or‑break nature of bringing a device or compound to clinical study. While a SaaS product can be coded and launched with a few hundred thousand dollars,...
Digital Surgery, How George Murgatroyd GM & VP of Medtronic Sees AI Transforming the OR!
The podcast features George Murgatroyd, Medtronic’s VP of Digital Technologies, discussing how artificial intelligence is poised to transform the operating room. He argues that current practices—surgeons still relying on USB sticks and DVDs for case review—are obsolete, and that high‑compute...
MD&M 2026 Keynote: $6.1B Advice From Ray Cohen and Tom West!
The MD&M West 2026 keynote, titled “Disrupting the Status Quo: Are We Innovating or Just Iterating?”, brought together veteran deal‑maker Ray Cohen and former J&J executive Tom West to debate what true innovation looks like in medical technology. Cohen warned that...
Trump MRI Debate and Longevity Scans with Sean O'Mara and Daniel J. Durand of Prenuvo
The episode centers on President Trump’s recent executive MRI and its broader implications for preventive health, featuring insights from Dr. Daniel Durand, Chief Medical Officer at Prenuvo, and Dr. Shawn Omera, a physician‑researcher focused on visceral fat and longevity. The...
The Book of Elon: Exploring Elon Musk’s Most Useful Ideas with Author Eric Jorgenson.
The episode spotlights the launch of "The Book of Elon," authored by Eric Jorgenson, a veteran curator of tech‑leader wisdom. Jorgenson, now CEO of Scribe Media, explains how the book distills Elon Musk’s relentless focus, first‑principles engineering, and audacious purpose...
Why Most People Fail at Listening and How to Fix It!
The video, hosted by Omar M. Katib, tackles why most people fail at listening and offers a framework to turn listening into a strategic advantage for sales, fundraising, and leadership. Katib distinguishes real listening—driven by the intent to understand, enjoy, learn,...
Venture:How Olympus Innovation Ventures Invests in MedTech Startups with Abby Hunter Syed
Olympus Innovation Ventures (OIV), the corporate venture arm of Olympus, is actively investing in MedTech startups focused on endoscopy, diagnostics, and digital health, as explained by director Abby Hunter‑Syed. The discussion highlights OIV’s strategic approach—prioritizing founder conviction, transparent founder‑investor relationships,...
US Surgical: VP of R&D Kurt Azarbarzin on Scaling Product and Innovation of a Billion Dollar Empire
The interview with Kurt Azarbarzin, US Surgical’s longtime VP of R&D, chronicles how the company grew from a modest stapler maker in the early 1980s into a multi‑billion‑dollar empire that helped define modern laparoscopic surgery. Azarbarzin describes the shift from open...
US Surgical's $1 Billion Lesson and the Laparoscopic Revolution of the 90s
US Surgical’s 1990s laparoscopic revolution was ignited when senior director Lee Cohen uncovered an illegal off‑label experiment and convinced CEO Leon Hirsch to stake the entire company on the technology. The bold "Green Beret" sales force trained roughly 40,000 surgeons,...
US Surgical’s Founding History: How Leon Hirsch Built Medicine’s Most Infamous Device Company Now!
US Surgical, founded by high‑school dropout Leon C. Hirsch, transformed a niche Russian surgical device into a 90% market monopoly that defined modern minimally invasive surgery. Hirsch risked his life savings, built the aggressive "Organ Grinder" sales training, and deployed...